Factors Associated with Herpes Zoster Vaccination in the Elderly
Article Sidebar
Main Article Content
Abstract
Objective: This study aimed to identify factors that determine the intention to obtain herpes zoster vaccination among the elderly in Thailand.
Design: A cross-sectional study.
Materials and Methods: Data was collected using a self-administered questionnaire in participants aged 60 years and above who visited the Comprehensive Geriatric Clinic at King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, in September 2019.
Results: Of the 428 participants who completed the questionnaire, 199 respondents were in the vaccinated/intended group, and 229 were in the unintended group. The logistic regression analysis showed a significant association between herpes zoster vaccination and perception of vaccine benefit (aOR 6.14, 95% CI 2.59–14.57), perception of the severity and complication of herpes zoster (aOR 2.75, 95% CI 1.24–6.13), the recommendation from healthcare providers and media (aOR 2.46, 95% CI 1.50–4.04), family members or friends with a history of zoster (aOR 1.96, 95% CI 1.25–3.08), knowledge about herpes zoster vaccine (aOR 1.91, 95% CI 1.19–3.07), and concern of side effects (aOR 0.52, 95% CI 0.32–0.84).
Conclusion: This study shows that perceiving the vaccine's benefits is the foremost decisive factor for obtaining herpes zoster vaccination. Promoting suggestive information on immunization may increase vaccine coverage in the Thai elderly.
Keywords: Herpes zoster vaccine, Vaccination, Elderly, Associated factors
Article Details
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
2. Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16(1):25.
3. Laing KJ, Ouwendijk WJD, Koelle DM, Verjans GMGM. Immunobiology of varicella-zoster virus infection. J Infect Dis. 2018;218(Suppl 2):S68-S74.
4. Araujo LQ, Macintyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes. 2007;14 Suppl 2:40A-4A.
5. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8(1):37.
6. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-84.
7. สมาคมโรคติดเชื้อแห่งประเทศไทย. คำแนะนำการให้วัคซีนป้องกันโรคสำหรับผู้ใหญ่และผู้สูงอายุ (Recommended adult and elderly immunization schedule) ปี พ.ศ. 2561. กรุงเทพฯ: สมาคมโรคติดเชื้อแห่งประเทศไทย; 2561.
8. Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, et al. A report on the status of vaccination in Europe. Vaccine. 2018;36(33):4979-92.
9. Advisory Committee on Immunization Practices. Recommended adult immunization schedule, United States, 2019. Ann Intern Med. 2019;170(3):182-92.
10. Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons; 1977.
11. สำนักงานสถิติแห่งชาติ. สถิติประชากรศาสตร์ ประชากรและเคหะ [อินเทอร์เน็ต]. กรุงเทพฯ: สำนักงานสถิติแห่งชาติ; 2563 [เข้าถึงเมื่อ 3 มี.ค. 2563]. เข้าถึงได้จาก: http://statbbi.nso.go.th/staticreport/page/sector/th/01.aspx.
12. Zhang D, Johnson K, Newransky C, Acosta CJ. Herpes zoster vaccine coverage in older adults in the U.S., 2007-2013. Am J Prev Med. 2017;52(1):e17-e23.
13. Klett-Tammen CJ, Krause G, Seefeld L, Ott JJ. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health. 2016;16:121.
14. Higuchi M, Narumoto K, Goto T, Inoue M. Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study. BMC Fam Pract. 2018;19(1):153.
15. Opstelten W, van Essen GA, Hak E. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly. Vaccine. 2009;27(2):192-6.
16. Stefanati A, Valente N, Lupi S, Previato S, Giordani M, Gabutti G. Herpes zoster vaccination in the elderly subjects: improving awareness and uptake. Patient Intell. 2015(7):15-20.
